Zurich Cantonal Bank
NUVB icon

Zurich Cantonal Bank’s Nuvation Bio NUVB Stock Holding History

Zurich Cantonal Bank’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-43,050
Closed -$386K – 3184
2025
Q4 		$386K Buy
+43,050
New +$267K ﹤0.01% 1923

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Zurich Cantonal Bank's NUVB Position: Q2 2026 in Review

Zurich Cantonal Bank held its Nuvation Bio (NUVB) position steady in Q2 2026 at 50,230 shares worth $285K. The position accounts for ﹤0.01% of the portfolio, ranked #2206.

Zurich Cantonal Bank first reported a position in NUVB in Q2 2021 and has held it in 18 quarters since. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • Zurich Cantonal Bank held 50,230 shares of Nuvation Bio worth $285K as of Q2 2026.
  • Zurich Cantonal Bank left its Nuvation Bio share count unchanged in Q2 2026.
  • Nuvation Bio made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q2 2026, its #2206 holding.
  • Zurich Cantonal Bank first reported a position in Nuvation Bio in Q2 2021 and has held it in 18 quarters since.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.